Abstract
Immunotherapy transformed oncology in the last decade, albeit the biomarker development was lagged behind. Recently, there is an interest in blood-based non-invasive biomarkers to predict prognosis in patients treated with immune checkpoint inhibitors (ICIs). The albumin-globulin ratio (AGR) could be a prognostic biomarker in patients with cancer, although the data is limited in patients treated with ICIs.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Annals of oncology : official journal of the European Society for Medical Oncology
Paper Title
Journal
Date
